LB Pharmaceuticals Inc
LBRX
$18.76
$0.271.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -3.56M | -5.09M | -5.09M | -14.18M | |
| Total Depreciation and Amortization | 81.00K | 77.50K | 77.50K | 5.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | 3.22M | |
| Total Other Non-Cash Items | 199.00K | 157.00K | 157.00K | -1.08M | |
| Change in Net Operating Assets | -97.00K | -2.01M | -2.01M | -10.00M | |
| Cash from Operations | -3.37M | -6.87M | -6.87M | -22.04M | |
| Capital Expenditure | 0.00 | -6.00K | -6.00K | -443.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -44.84M | 2.50M | 2.50M | 29.32M | |
| Cash from Investing | -44.84M | 2.49M | 2.49M | 28.87M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 328.00M | -- | -- | 20.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -24.27M | -- | -- | 0.00 | |
| Cash from Financing | 303.73M | -- | -- | 20.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 255.52M | -4.37M | -4.37M | 6.86M | |